Pre-market: Rally likely to continue

The Indian markets are expected to continue their winning streak this week on the back of renewed buying interest from foreign institutional investors and encouraging U-S jobs data.

Riding high on frantic buying by foreign funds, the benchmark Sensex posted gains for the fifth consecutive week and settled almost 371 points higher at 17,604 on Friday.

Asian shares rose on Monday as surprisingly robust US jobs data bolstered investor risk appetite. MSCI's broadest index of Asia-Pacific shares outside Japan rose 0.6 per cent, while the Japan's Nikkei average opened up 1.2 per cent. South Korea's Kospi Composite moved up 0.7 per cent.

Back home, the Nifty may face resistance around 5,355 – 5,375, while seek support around 5,295 – 5,275 levels, technical analysts say. The SGX Nifty was trading at 5,388 levels, up 0.9 per cent.

Among individual stocks, Piramal Healthcare will be in focus today on reports that the company has bought an additional 5.5 per cent stake in Vodafone.

Dr Reddy’s Laboratories could also be in limelight on reporting an 88 per cent jump in net profit for the quarter ended December 2011.

Srei Infrastructure Finance will react to a 52 per cent decline in net profit to 19.40 crore for the quarter ended December 2011.

The board of directors of Kale Consultants have approved a share buy-back at a price not exceeding 160 per equity share. This could bring the stock back in focus today.

Also keep a tab on Adani Power, G-S-K Consumer Healthcare, Hindustan Unilever, National Aluminium, Hindustan Construction and SpiceJet as they will announce their respective December quarter results today.